NSCLC is a common cancer. Accurate and early staging has a significant impact on outcome. EBUS-TBNA of involved mediastinal lymph nodes is critical. Molecular markers could improve mediastinal staging.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age ≥ 18 years
Samples are collected before surgery or before any therapy
ECOG 0 or 1
Clinical stage I-II, T1-2, N0-1, M0)
Surgically respectable
Patient with enlarged med. lymphnodes (control group)
